solutions syneos-one full-service-development 
XTalks
MARCH 5, 2021
The acquisition will see ICON plc, global provider of development and commercialization services to the pharmaceutical, biotechnology and medical device industries, expand its portfolio to leverage PRA’s mobile and connected health platforms, along with its data and information solutions. Accelerating Development.
Delveinsight
AUGUST 13, 2021
Clinical trials are an essential part of the drug development process. While clinical trials are pivotal to analyze the efficacy of any new therapy or drug, every year, a lot is spent on clinical trials. According to a study by the Tufts Centre for the Study of Drug Development, approximately USD 2.6B Why the Need?
Expert insights. Personalized for you.
98 
Let's personalize your content